Laparoscopic esophagomyotomy for achalasia: does anterior hemifundoplication affect clinical outcome?
- PMID: 15166957
- PMCID: PMC1356286
- DOI: 10.1097/01.sla.0000128683.61539.9f
Laparoscopic esophagomyotomy for achalasia: does anterior hemifundoplication affect clinical outcome?
Abstract
Objective: To determine whether the addition of anterior hemifundoplication to laparoscopic esophagomyotomy for achalasia yields better clinical outcomes than laparoscopic esophagomyotomy alone.
Summary background data: Although hemifundoplication may prevent gastroesophageal reflux after esophagomyotomy for achalasia, it may also lead to persistent dysphagia in these patients with esophageal aperistalsis.
Methods: This is a retrospective study of 51 consecutive patients (mean age 47.5 +/- 12.6 years) who had laparoscopic esophagomyotomy for achalasia by our group between August 1995 and January 2001. In 29 patients (57%) an anterior hemifundoplication was added to the esophagomyotomy. In 22 patients (43%), no wrap was added. Patients scored (0 = none; 1 = mild; 2 = moderate; 3 = severe) symptom severity (dysphagia, regurgitation, heartburn, chest pain) preoperatively and postoperatively. Weight gain, use of gastrointestinal (GI) medication, tolerance to food, and patient satisfaction were also assessed.
Results: Mean patient follow-up was 33 months, and there were no operative deaths. Four patients were converted to open operation (8%). The wrap and no wrap groups were similar in terms of esophageal dilation, preoperative symptom severity and duration (5.7 +/- 7.1 versus 6.1 +/- 7.0 years), and preoperative weight loss (18 +/- 15 versus 20 +/- 20 pounds). Both groups had similar improvement in symptom grade postoperatively and equivalent satisfaction rates (86%). Postoperative weight gain, GI medication use, and food intolerance was also similar. Postoperatively, patients in the wrap group did not have higher dysphagia scores or lower heartburn scores than the no wrap group.
Conclusion: The addition of anterior hemifundoplication to esophagomyotomy for achalasia does not improve or worsen clinical results.
Figures
References
-
- Kahrilas PJ, Pandolfino JE. Motility disorders of the esophagus. In: Yamada, et al. Textbook of Gastroenterology, 4th ed. Philadelphia: Lippincott, Williams, and Wilkins; 2003.
-
- Goldblum JR, Rice TW, Richter JE. Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology. 1996;111:648–654. - PubMed
-
- Pasricha PJ, Ravich WJ, Hendrix TR, et al. Intrasphincteric injection of botulinum toxin for the treatment of achalasia. N Engl J Med. 1995;322:774–778. - PubMed
-
- Parkman HP, Reynolds JC, Ouyang A, et al. Pneumatic dilatation or esophagomyotomy treatment for idiopathic achalasia: clinical outcomes and cost analysis. Dig Dis Sci. 1993;38:75–85. - PubMed
-
- Patti MG, Fisichella PM, Perretta S, et al. Impact of minimally invasive surgery on the treatment of esophageal achalasia: a decade of change. J Am Coll Surg. 2003;196:698–705. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
